Biolik to market Sinovac's hepatitis A vaccine in Ukraine
This article was originally published in Scrip
Executive Summary
Sinovac Biotech, one of China's main biotech companies, has begun clinical trials of its inactivated hepatitis A vaccine Healive in Ukraine. The trials are being conducted by Biolik Biopharmaceutical, a Kharkov-based company, and that should enable Biolik to apply for regulatory approval in the country.